Faculty

Cathy Critchlow

Affiliate Professor, Epidemiology


ccritchl@amgen.com

Education

PhD Epidemiology, University of Washington, 1993

Contact


ccritchl@amgen.com

View Website »

Bio

Since 2004, Dr. Critchlow has focused on epidemiologic methods relevant to pharmacoepidemiology, conducting studies and developing observational research strategies in support of drug development and assessment of post-market drug effectiveness and safety.  She currently heads the Center for Observational Research at Amgen, Inc. 

Research Interests

Dr. Critchlow’s research focuses on pharmacoepidemiology methods to assess the evolving benefit:risk profiles of medications used in clinical practice populations, including application of methods to control for confounding-by-indication in studies of treatment effects, post-marketing drug surveillance studies and longitudinal data analysis using large databases.

Recent Publications (PubMed)

Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study.
(2022 Feb 28)
BMJ Open 12(2): e055137
Page JH, Londhe AA, Brooks C, Zhang J, Sprafka JM, Bennett C, Braunlin M, Brown CA, Charuworn P, Cheng A, Gill K, He F, Ma J, Petersen J, Ayodele O, Bao Y, Carlson KB, Chang SC, Devercelli G, Jonsson-Funk M, Jiang J, Keenan HA, Ren K, Roehl KA, Sanders L, Wang L, Wei Z, Xia Q, Yu P, Zhou L, Zhu J, Gondek K, Critchlow CW, Bradbury BD

Machine learning applications for therapeutic tasks with genomics data.
(2021 Oct 8)
Patterns (N Y) 2(10): 100328
Huang K, Xiao C, Glass LM, Critchlow CW, Gibson G, Sun J

A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China.
(2022 Jan)
Ther Innov Regul Sci 56(1): 137-144
Storm NE, Chang W, Lin TC, Lange JL, Bradbury B, Critchlow CW, Galson SK

Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study.
(2021 Aug 6)
BMJ Open 11(8): e051588
Zhu J, Wei Z, Suryavanshi M, Chen X, Xia Q, Jiang J, Ayodele O, Bradbury BD, Brooks C, Brown CA, Cheng A, Critchlow CW, Devercelli G, Gandhi V, Gondek K, Londhe AA, Ma J, Jonsson-Funk M, Keenan HA, Manne S, Ren K, Sanders L, Yu P, Zhang J, Zhou L, Bao Y

Real-world evidence to support regulatory decision making: New or expanded medical product indications.
(2021 Jun)
Pharmacoepidemiol Drug Saf 30(6): 685-693
Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA

Show complete publication list

In the News

No news articles at this time.